Evidence map›Paper›PMID 20844224›Full record

ArticleJournal of clinical microbiology2010

Changing epidemiology of methicillin-resistant Staphylococcus aureus in Iceland from 2000 to 2008: a challenge to current guidelines.

Barbara Juliane Holzknecht, Hjördis Hardardottir, Gunnsteinn Haraldsson, Henrik Westh, Freyja Valsdottir, Kit Boye, Sigfus Karlsson, Karl Gustaf Kristinsson, Olafur Gudlaugsson

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Changing epidemiology of methicillin-resistant Staphylococcus aureus in a low endemicity area-new challenges for MRSA control.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  4. The Effect of Age and Sampling Site on the Outcome ofAnimals : an open access journal from MDPI · 2020
    Article
  5. Distribution of the Most PrevalentFrontiers in microbiology · 2018
    Review
  6. Article
  7. Community-acquired methicillin-resistantInfection and drug resistance · 2018
    Article
  8. Observational
  9. Origin and proliferation of multiple-drug resistance in bacterial pathogens.Microbiology and molecular biology reviews : MMBR · 2015
    Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Barbara Juliane HolzknechtDepartment of Internal Medicine, Landspitali University Hospital, Hringbraut, IS-101 Reykjavik, Iceland. barbarah@web.de
Hjördis Hardardottir
Gunnsteinn Haraldsson
Henrik Westh
Freyja Valsdottir
Kit Boye
Sigfus Karlsson
Karl Gustaf Kristinsson
Olafur Gudlaugsson

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) is continuously changing. Iceland has a low incidence of MRSA. A "search and destroy" policy (screening patients with defined risk factors and attempting eradication in carriers) has been implemented since 1991. Clinical and microbiological data of all MRSA patients from the years 2000 to 2008 were collected prospectively. Isolates were characterized by pulsed-field gel electrophoresis (PFGE), sequencing of the repeat region of the Staphylococcus protein A gene (spa typing), staphylococcal cassette chromosome mec (SCCmec) typing, and screening for the Panton-Valentine leukocidin (PVL) gene. Two hundred twenty-six infected (60%) or colonized (40%) individuals were detected (annual incidence 2.5 to 16/100,000). From 2000 to 2003, two health care-associated outbreaks dominated (spa types t037 and t2802), which were successfully controlled with extensive infection control measures. After 2004, an increasing number of community-associated (CA) cases without relation to the health care system occurred. A great variety of clones (40 PFGE types and 49 spa types) were found, reflecting an influx of MRSA from abroad. The USA300 and Southwest Pacific (SWP) clones were common. SCCmec type IV was most common (72%), and 38% of the isolates were PVL positive. The incidence of MRSA in Iceland has increased since 1999 but remains low and has been stable in the last years. The search and destroy policy was effective to control MRSA in the health care setting. However, MRSA in Iceland is now shifting into the community, challenging the current Icelandic guidelines, which are tailored to the health care system.

Indexed as

AdolescentAdultAgedAged, 80 and overBacterial ToxinsBacterial Typing TechniquesChildChild, PreschoolCommunity-Acquired InfectionsCross InfectionDisease OutbreaksDNA FingerprintingElectrophoresis, Gel, Pulsed-FieldExotoxinsFemaleHumansBacterial ToxinsExotoxinsLeukocidinsPanton-Valentine leukocidinVirulence Factors

Identifiers

PMID20844224
PMCPMC3020889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.